A complex interplay of factors causes diabetic nephropathy

Metabolism: Clinical and Experimental

Volumn 60, Issue 5, 2011, Pages 591-593

  Stanton, Robert C ^a   King, George L ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CARDIOVASCULAR DISEASE; DIABETIC NEPHROPATHY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW;

EID: 79955033725     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.10.004     Document Type: Editorial

References (23)

1. www.usrds.org. United States renal data survey. 2010.
2. Lewko B., and Stepinski J. Hyperglycemia and mechanical stress: targeting the renal podocyte J Cell Physiol 221 2009 288 295
3. Abbate M., Zoja C., and Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 17 2006 2974 2984 (Pubitemid 44707757)
4. Zatz R., Dunn B.R., and Meyer T.W. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension J Clin Invest 77 1986 1925 1930 (Pubitemid 16062649)
5. Mauer M., Zinman B., and Gardiner R. Renal and retinal effects of enalapril and losartan in type 1 diabetes N Engl J Med 361 2009 40 51
6. Fioretto P., and Mauer M. Histopathology of diabetic nephropathy Semin Nephrol 27 2007 195 207 (Pubitemid 46550314)
7. Kumar D., Robertson S., and Burns K.D. Evidence of apoptosis in human diabetic kidney Mol Cell Biochem 259 2004 67 70 (Pubitemid 38519217)
8. Noh H., and King G.L. The role of protein kinase c activation in diabetic nephropathy Kidney Int Suppl 2007 S49 53
9. Ziyadeh F.N., and Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy Curr Diabetes Rev 4 2008 39 45 (Pubitemid 351210971)
10. Busch M., Franke S., and Ruster C. Advanced glycation end-products and the kidney Eur J Clin Invest 40 2010 742 755
11. Tuttle K.R. Protein kinase c-beta inhibition for diabetic kidney disease Diabetes Res Clin Pract 82 Suppl 1 2008 S70 S74
12. Forbes J.M., Coughlan M.T., and Cooper M.E. Oxidative stress as a major culprit in kidney disease in diabetes Diabetes 57 2008 1446 1454
13. Coughlan M.T., Thorburn D.R., and Penfold S.A. Rage-induced cytosolic ros promote mitochondrial superoxide generation in diabetes J Am Soc Nephrol 20 2009 742 752
14. Nam S.M., Lee M.Y., and Koh J.H. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property Diabetes Res Clin Pract 83 2009 176 182
15. Leopold J.A., Dam A., and Maron B.A. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity Nat Med 13 2007 189 197
16. Mehdi U.F., Adams-Huet B., and Raskin P. Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy J Am Soc Nephrol 20 2009 2641 2650
17. Yuan J., Jia R., and Bao Y. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats J Renin Angiotensin Aldosterone Syst 8 2007 118 126 (Pubitemid 350148448)
18. Fonseca S.G., Burcin M., and Gromada J. Endoplasmic reticulum stress in beta-cells and development of diabetes Curr Opin Pharmacol 9 2009 763 770
19. Xu Y., Osborne B.W., and Stanton R.C. Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex Am J Physiol Renal Physiol 289 2005 F1040 F1047
20. Eremina V., Jefferson J.A., and Kowalewska J. VEGF inhibition and renal thrombotic microangiopathy N Engl J Med 358 2008 1129 1136 (Pubitemid 351398487)
21. Isermann B., Vinnikov I.A., and Madhusudhan T. Activated protein c protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis Nat Med 13 2007 1349 1358 (Pubitemid 350073598)
22. Wagle A., Jivraj S., and Garlock G.L. Insulin regulation of glucose-6-phosphate dehydrogenase gene expression is rapamycin-sensitive and requires phosphatidylinositol 3-kinase J Biol Chem 273 1998 14968 14974 (Pubitemid 28272789)
23. Keenan H.A., Sun J.K., and Levine J. Residual insulin production and pancreatic {beta} cell turnover after 50 years of diabetes: Joslin medalist study Diabetes 2010